Guidelinehigh evidence

Practice guideline on the prevention and treatment of central line-associated bloodstream infection: Part 2 - Treatment.

Journal of intensive medicine·June 1, 2026·PMID 42164585

Why it matters

CLABSI remains a leading cause of healthcare-associated infections in ICUs, increasing mortality, length of stay, and costs. This guideline provides updated, evidence-based strategies for catheter management and antimicrobial therapy, addressing evolving resistance patterns and new antimicrobials.

Infographic summary of Practice guideline on the prevention and treatment of central line-associated bloodstream infection: Part 2 - Treatment.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled